NCT04216095View on ClinicalTrials.gov

Comparative Effectiveness Clinical Trial of MST Compared to ECT in Major Depressive Disorder

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 7, 2013

Primary Completion Date

October 7, 2015

Study Completion Date

October 7, 2015

Conditions
Major Depressive Disorder
Interventions
DEVICE

Electroconvulsive Therapy (n=30)

Right unilateral (RUL) ECT (n=15) or bitemporal (BT) ECT (n=15) using a Thymatron IV device (Somatics LLC, USA) twice weekly.

DEVICE

Magnetic Seizure Therapy (n=30)

High-dose magnetic seizure therapy (HD-MST) over the vertex using Magstim Theta device (Magstim Company Limited, Whitfield, Wales, UK) at 100% maximal output of the device (constant), with pulse frequency 100Hz and train duration 10 seconds twice weekly.

All Listed Sponsors
collaborator

Nagy A. Youssef (Consultant on the MST technique)

UNKNOWN

lead

Tanta University

OTHER

NCT04216095 - Comparative Effectiveness Clinical Trial of MST Compared to ECT in Major Depressive Disorder | Biotech Hunter | Biotech Hunter